Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Systematic Review and Meta-analysis of Carbapenem Resistance of Acinetobacter baumannii in Iran

Author(s): Pegah Shakib, Zeinab Babaie Choolandaimy, Faranak Rezaie, Mahmood Bahmani and Somayeh Delfani*

Volume 20, Issue 5, 2020

Page: [611 - 619] Pages: 9

DOI: 10.2174/1871526519666190930104715

Price: $65

Abstract

Background: The prevalence of carbapenem resistance in Acinetobacter baumannii has been increasing worldwide, and therapeutic options are extremely limited. We performed a systematic review to evaluate the phenotypic and genotypic carbapenem resistance in A.baumannii reported in Iran.

Methods: We systematically searched Pub Med, Web of Science Direct, and Google scholar databases to identify studies addressing the carbapenem resistance of A. baumannii. The selected papers were published between 2005 and 2016, but the sample collection period was between 2002 and 2016. To estimate the prevalence, the Der Simonian and Laird randomized models, a 95% confidence interval, was used. For the heterogeneity check, I2 test was used. The Egger test was used to check the propagation bias.

Results: Analysis of data indicates that there was an increase in resistance to carbapenems from 4.5% in 2005 to a 100% prevalence rate in 2016 (65.4 (95% CI: 58.8 – 71.6).

Conclusion: According to the results of this study, the rate of resistance to carbapenem in A.baumannii has been increasing in Iran. The presence of carbapenem-resistant isolates is a major concern, because carbapenem is the main drug used against Multi Drug Resistant (MDR) isolates.

Keywords: Carbapenem resistance, Acinetobacter baumannii, phenotypic, genotypic, multi drug resistant, nosocomial pathogens.

[1]
Huang, L.; Sun, L.; Yan, Y. Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period. J. Microbiol., 2013, 51(1), 113-117.
[http://dx.doi.org/10.1007/s12275-013-2341-4] [PMID: 23456719]
[2]
Nie, L.; Lv, Y.; Yuan, M.; Hu, X.; Nie, T.; Yang, X.; Li, G.; Pang, J.; Zhang, J.; Li, C.; Wang, X.; You, X. Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China. Acta Pharm. Sin. B, 2014, 4(4), 295-300.
[http://dx.doi.org/10.1016/j.apsb.2014.06.004] [PMID: 26579398]
[3]
Poirel, L.; Nordmann, P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect., 2006, 12(9), 826-836.
[http://dx.doi.org/10.1111/j.1469-0691.2006.01456.x] [PMID: 16882287]
[4]
Turton, J.F.; Woodford, N.; Glover, J.; Yarde, S.; Kaufmann, M.E.; Pitt, T.L. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol., 2006, 44(8), 2974-2976.
[http://dx.doi.org/10.1128/JCM.01021-06] [PMID: 16891520]
[5]
Mugnier, P.D.; Poirel, L.; Naas, T.; Nordmann, P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis., 2010, 16(1), 35-40.
[http://dx.doi.org/10.3201/eid1601.090852] [PMID: 20031040]
[6]
Bou, G.; Oliver, A.; Martínez-Beltrán, J. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother., 2000, 44(6), 1556-1561.
[http://dx.doi.org/10.1128/AAC.44.6.1556-1561.2000] [PMID: 10817708]
[7]
Mendes, R.E.; Bell, J.M.; Turnidge, J.D.; Castanheira, M.; Jones, R.N. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J. Antimicrob. Chemother., 2009, 63(1), 55-59.
[http://dx.doi.org/10.1093/jac/dkn434] [PMID: 18957398]
[8]
Hasan, B.; Perveen, K.; Olsen, B.; Zahra, R. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. J. Med. Microbiol., 2014, 63(Pt 1), 50-55.
[http://dx.doi.org/10.1099/jmm.0.063925-0] [PMID: 24085817]
[9]
Pesesky, M.W.; Hussain, T.; Wallace, M.; Wang, B.; Andleeb, S.; Burnham, C-A.D.; Dantas, G. KPC and NDM-1 genes in related Enterobacteriaceae strains and plasmids from Pakistan and the United States. Emerg. Infect. Dis., 2015, 21(6), 1034-1037.
[http://dx.doi.org/10.3201/eid2106.141504] [PMID: 25988236]
[10]
Calhoun, J.H.; Murray, C.K.; Manring, M.M. Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin. Orthop. Relat. Res., 2008, 466(6), 1356-1362.
[http://dx.doi.org/10.1007/s11999-008-0212-9] [PMID: 18347888]
[11]
Bou, G.; Martínez-Beltrán, J. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother., 2000, 44(2), 428-432.
[http://dx.doi.org/10.1128/AAC.44.2.428-432.2000] [PMID: 10639377]
[12]
Rahbar, M.; Mehrgan, H.; Aliakbari, N.H. Prevalence of antibiotic-resistant Acinetobacter baumannii in a 1000-bed tertiary care hospital in Tehran, Iran. Indian J. Pathol. Microbiol., 2010, 53(2), 290-293.
[http://dx.doi.org/10.4103/0377-4929.64333] [PMID: 20551535]
[13]
Soroush, S.; Haghi-Ashtiani, M.T.; Taheri-Kalani, M.; Emaneini, M.; Aligholi, M.; Sadeghifard, N.; Pakzad, I.; Abedini, M.; Yasemi, M.; Paiman, H. Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children’s Medical Center of Tehran: a 6-year prospective study. Acta Med. Iran., 2010, 48(3), 178-184.
[PMID: 21137655]
[14]
Feizabadi, M.M.; Fathollahzadeh, B.; Taherikalani, M.; Rasoolinejad, M.; Sadeghifard, N.; Aligholi, M.; Soroush, S.; Mohammadi-Yegane, S. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn. J. Infect. Dis., 2008, 61(4), 274-278.
[PMID: 18653968]
[15]
Taherikalani, M.; Fatolahzadeh, B.; Emaneini, M.; Soroush, S.; Feizabadi, M.M. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol., 2009, 32(3), 265-271.
[PMID: 19845108]
[16]
Peymani, A.; Nahaei, M-R.; Farajnia, S.; Hasani, A.; Mirsalehian, A.; Sohrabi, N.; Abbasi, L. High prevalence of metallo-beta-lactamase-producing acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn. J. Infect. Dis., 2011, 64(1), 69-71.
[PMID: 21266761]
[17]
Shahcheraghi, F.; Abbasalipour, M.; Feizabadi, M.; Ebrahimipour, G.; Akbari, N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran. J. Microbiol., 2011, 3(2), 68-74.
[PMID: 22347585]
[18]
Asadollahi, P; Akbari, M; Soroush, S; Taherikalani, M; Asadollahi, K; Sayehmiri, K Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. journal of the International Society for Burn Injuries, 2012, 38(8), 1198-203.
[http://dx.doi.org/10.1016/j.burns.2012.04.008]
[19]
Shakibaie, M.R.; Adeli, S.; Salehi, M.H. Antibiotic resistance patterns and extended-spectrum β-lactamase production among Acinetobacter spp. isolated from an intensive care Unit of a hospital in Kerman, Iran. Antimicrob. Resist. Infect. Control, 2012, 1(1), 1.
[http://dx.doi.org/10.1186/2047-2994-1-1] [PMID: 22958725]
[20]
Azimi, L.; Lari, A.R.; Talebi, M.; Namvar, A.E.; Jabbari, M. Comparison between phenotypic and PCR for detection of OXA-23 type and metallo-beta-lactamases producer Acinetobacter spp. GMS Hyg. Infect. Control, 2013, 8(2), Doc16.
[PMID: 24327942]
[21]
NajarPeerayeh S. Molecular epidemiology of carbapenem resistance in Acinetobacter baumannii isolates in Shahid Mohammadi Hospital, Bandar Abbas, Iran. Hormozgan Medical Journal., 2015, 19(1), 16-24.
[22]
Vakili, B; Fazeli, H; Shoaei, P; Yaran, M; Ataei, B; Khorvash, F Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences,, 2014, 19(Suppl 1) S67
[23]
Khalilzadegan, S.; Sade, M.; Godarzi, H.; Eslami, G.; Hallajzade, M.; Fallah, F.; Yadegarnia, D. Beta-lactamase encoded genes blaTEM and blaCTX among Acinetobacter baumannii species isolated from medical devices of intensive care units in Tehran hospitals. Jundishapur J. Microbiol., 2016, 9(5)e14990
[http://dx.doi.org/10.5812/jjm.14990] [PMID: 27540447]
[24]
Mazarei, A.; Mardaneh, J. Acinetobacter baumannii-calcoaceticus Complex: Detection Extensively Drug-Resistant, Survey Carbapenemases Production, and Determination MIC Values for Imipenem. Horizon, 2015, 21(4)
[25]
Hrenovic, J.; Seruga Music, M.; Durn, G.; Dekic, S.; Hunjak, B.; Kisic, I. Carbapenem-Resistant Acinetobacter baumannii Recovered from Swine Manure; Microbial Drug Resistance, 2019.
[http://dx.doi.org/10.1089/mdr.2018.0087]
[26]
Izadpour, F.; Ranjbari, N.; Aramesh, M-R.; Moosavian, M. ShahAli, S.; Larki, F.; Tabesh, H.; Morvaridi, A. An investigation of antibacterial resistance patterns among Acinetobacter baumannii and Pseudomonas aeruginosa isolates collected from intensive care units of a university-affiliated hospital in Ahvaz, Iran. Jundishapur J. Microbiol., 2016, 9(8)e35624
[http://dx.doi.org/10.5812/jjm.35624] [PMID: 27800136]
[27]
Shoja, S.; Moosavian, M.; Rostami, S.; Abbasi, F.; Tabatabaiefar, M.A.; Peymani, A. Characterization of oxacillinase and metallo-β-lactamas genes and molecular typing of clinical isolates of Acinetobacter baumannii in Ahvaz, South-West of Iran. Jundishapur J. Microbiol., 2016, 9(5)e32388
[http://dx.doi.org/10.5812/jjm.32388] [PMID: 27540456]
[28]
Azizi, O.; Shakibaie, M.R.; Modarresi, F.; Shahcheraghi, F. Molecular detection of class-D OXA carbapenemase genes in biofilm and non-biofilm forming clinical isolates of Acinetobacter baumannii. Jundishapur J. Microbiol., 2015, 8(1)e21042
[http://dx.doi.org/10.5812/jjm.21042] [PMID: 25789134]
[29]
Salimizand, H.; Modarresi, F.; Azizi, O.; Mansouri, S.; Rahmati, M.; Barkhordari, K. Antimicrobial Profile and Phenotypic Metallo-β-Lactamase Detection of Acinetobacter baumannii Isolated From Clinical and Environmental Specimens. Zahedan J. Res. Med. Sci., 2015, 17(6)
[http://dx.doi.org/10.17795/zjrms993]
[30]
Alavi-Moghadam, M.; Miri, M.; Mokhtari, M.; Kouchek, M.; Goharani, R.; Sistanzad, M.; Safari, S.; Solouki, M. Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU). Caspian J. Intern. Med., 2014, 5(3), 186-187.
[PMID: 25202450]
[31]
Ahmadi, K.; Mardaneh, J.; Saadat, S. Determination antimicrobial resistance profile of Acinetobacter strains isolated from hospitalized patients in Different Part of Taleghani Hospital (Ahvaz, Iran). ISMJ, 2014, 17(4), 620-628.
[32]
Sharif, M.; Mirnejad, R.; Amirmozafari, N. Molecular identification of TEM and SHV extended spectrum β-lactamase in clinical isolates of Acinetobacter baumannii from Tehran hospitals. J Gen Microb Immun., 2014, 2, 1-9.
[http://dx.doi.org/10.5899/2014/jgmi-00020]
[33]
Nasrolahei, M.; Zahedi, B.; Bahador, A.; Saghi, H.; Kholdi, S.; Jalalvand, N.; Esmaeili, D. Distribution of bla(OXA-23), ISAba, Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran. Ann. Clin. Microbiol. Antimicrob., 2014, 13(1), 38.
[http://dx.doi.org/10.1186/s12941-014-0038-0] [PMID: 25252850]
[34]
Mohajeri, P.; Farahani, A.; Feizabadi, M.M.; Davoodabadi, A.; Noroozi, B. The prevalence of ESBL isolates of Acinetobacter baumannii using pulsed-field gel electrophoresis. Zahedan J. Res. Med. Sci., 2014, 16(11), 20-23.
[35]
Abdi-Ali, A.; Hendiani, S.; Mohammadi, P.; Gharavi, S. Assessment of biofilm formation and resistance to imipenem and ciprofloxacin among clinical isolates of Acinetobacter baumannii in Tehran. Jundishapur J. Microbiol., 2014, 7(1)e8606
[http://dx.doi.org/10.5812/jjm.8606] [PMID: 25147652]
[36]
Fallah, F; Noori, M; Hashemi, A; Goudarzi, H; Karimi, A Erfanimanesh, S Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran Scientifica., 2014, 2014.
[37]
Soltani, R.; Ehsanpoor, M.; Khorvash, F.; Shokri, D. Antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital. J. Res. Pharm. Pract., 2014, 3(1), 6-11.
[http://dx.doi.org/10.4103/2279-042X.132703] [PMID: 24991629]
[38]
Mohajeri, P.; Farahani, A.; Feizabadi, M.M.; Ketabi, H.; Abiri, R.; Najafi, F. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran. J. Microbiol., 2013, 5(3), 195-202.
[PMID: 24475323]
[39]
Haeili, M.; Ghodousi, A.; Nomanpour, B.; Omrani, M.; Feizabadi, M.M. Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011. J. Infect. Dev. Ctries., 2013, 7(4), 312-317.
[http://dx.doi.org/10.3855/jidc.2604] [PMID: 23592640]
[40]
Goudarzi, H.; Douraghi, M.; Ghalavand, Z.; Goudarzi, M. Assessment of antibiotic resistance pattern in Acinetobacter bumannii carrying bla oxA type genes isolated from hospitalized patients. Novelty in Biomedicine., 2013, 1(2), 54-61.
[41]
ALAEE N, BAHADOR A, HARZANDI N. Molecular epidemiology & antimicrobial resistance of acinetobacter baumannii isolated from namazi hospital, in shiraz by modified aflp analysis. 2013.
[42]
Safari, M.; Saidijam, M.; Bahador, A.; Jafari, R.; Alikhani, M.Y. High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. J. Res. Health Sci., 2013, 13(2), 162-167.
[PMID: 24077474]
[43]
Sade, M; Godarzi, H; Eslami, G; Fallah, F Molecular detection of beta-lactamase genes (blatem, blactx) drug resistant and Glutaraldehyde in isolates of Acinetobacter baumannii separated from surfaces and equipments in selected hospitals of Tehran by using Multiplex PCR method, 2013.
[44]
Azimi, L.; Rastegar Lari, A.; Alaghehbandan, R.; Alinejad, F.; Mohammadpoor, M.; Rahbar, M. KPC-producer gram negative bacteria among burned infants in Motahari Hospital, Tehran: first report from Iran. Ann. Burns Fire Disasters, 2012, 25(2), 74-77.
[PMID: 23233824]
[45]
Jafari, S.; Najafipour, S.; Kargar, M.; Abdollahi, A.; Mardaneh, J.; Fasihy Ramandy, M. Phenotypical evaluation of multi-drug resistant Acinetobacter baumannii. Journal of Fasa University of Medical Sciences., 2013, 2(4), 254-258.
[46]
Owlia, P; Azimi, L; Gholami, A; Asghari, B Lari, AR ESBL-and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients. Le infezioni in medicina: rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive. 2012, 20(3), 182-7.
[47]
Peymani, A.N.M.; Sohrabi, N. Clonal isolates of Acinetobacter baumannii with multiple drug resistance survey in Emam Reza hospital in Tabriz. J Infect Dis Trop Med., 2012, 17, 7-12.
[48]
Sohrabi, N; Farajnia, S; Akhi, MT; Nahaei, MR; Naghili, B Peymani, A Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran Microbial drug resistance., 2012, 18(4), 385-9.
[49]
Aminzadeh, Z.; Yaghubi, T. Drug-resistant post-neurosurgical nosocomial Acinetobacter baumannii meningitis in two Iranian hospitals. Afr. J. Biotechnol., 2012, 11(17), 4083-4084.
[http://dx.doi.org/10.5897/AJB11.3850]
[50]
Mirnejad, R.; Vafaei, S. Antibiotic resistance patterns and the prevalence of ESBLs among strains of Acinetobacter baumannii isolated from clinical specimens. The Journal of Genes. Microbes and Immunity., 2013, 2013, 1-8.
[http://dx.doi.org/10.5899/2013/jgmi-00002]
[51]
SA J-M. Sh B. Risk factors and antimicrobial susceptibility in ventilator associated pneumonia: a brief report. Tehran University Medical Journal TUMS Publications., 2012, 70(9), 577-582.
[52]
Karbasizade, V.; Heidari, L. Antimicrobial resistance of Acinetobacter baumannii isolated from Intensive Care Units of Isfahan hospitals, Iran. Majallah-i Danishkadah-i Pizishki-i Isfahan, 2012, 30(191)
[53]
Japoni, S.; Farshad, S.; Abdi Ali, A.; Japoni, A. Antibacterial susceptibility patterns and cross-resistance of acinetobacter, isolated from hospitalized patients, southern iran. Iran. Red Crescent Med. J., 2011, 13(11), 832-836.
[PMID: 22737424]
[54]
Mirnejad, R.; Mostofi, S.; Masjedian, F. Role of Class 2 integron in antibiotic susceptibility pattern of Acinetobacter baumannii strains isolated from hospitals in Tehran. Scientific Journal of Hamadan University of Medical Sciences., 2012, 18(4), 22-28.
[55]
Asadollahi, K.; Alizadeh, E.; Akbari, M.; Taherikalani, M.; Niakan, M.; Maleki, A.; Asadollahi, P.; Soroush, S.; Feizabadi, M.M.; Emaneini, M. The role of bla(OXA-like carbapenemase) and their insertion sequences (ISS) in the induction of resistance against carbapenem antibiotics among Acinetobacter baumannii isolates in Tehran hospitals. Roum. Arch. Microbiol. Immunol., 2011, 70(4), 153-158.
[PMID: 22568262]
[56]
Vahdani, P.; Yaghoubi, T.; Aminzadeh, Z. Hospital acquired antibiotic-resistant acinetobacter baumannii infections in a 400-bed hospital in Tehran, Iran. Int. J. Prev. Med., 2011, 2(3), 127-130.
[PMID: 21811653]
[57]
Jazani, N.; Babazadeh, H.; Sohrabpour, M.; Zartoshti, M.; Ghasemi Rad, M. The prevalence of extended spectrum beta-lactamases in Acinetobacter baumannii isolates from burn wounds in Iran. Internet J. Microbiol., 2011, 9(2)
[58]
Asadollahi, K.; Taherikalani, M.; Maleki, A.; Alizadeh, E.; Valadbaigi, H.; Soroush, S.; Maleki, H.; Asadollahi, P.; Emaneini, M. Diversity of aminoglycoside modifying enzyme genes among multidrug resistant Acinetobacter baumannii genotypes isolated from nosocomial infections in Tehran hospitals and their association with class 1 integrons. Acta Microbiol. Immunol. Hung., 2011, 58(4), 359-370.
[http://dx.doi.org/10.1556/AMicr.58.2011.4.11] [PMID: 22207293]
[59]
Mohammadtaheri, Z.; Pourpaki, M.; Mohammadi, F.; Namdar, R.; Masjedi, M-R. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009. Chemotherapy, 2010, 56(6), 478-484.
[http://dx.doi.org/10.1159/000321032] [PMID: 21099220]
[60]
Akbari, M.; Niakan, M.; Taherikalani, M.; Feizabadi, M.M.; Azadi, N.A.; Soroush, S.; Emaneini, M.; Abdolkarimi, A.; Maleki, A.; Hematian, A. Rapid identification of Iranian Acinetobacter baumannii strains by single PCR assay using BLA oxa-51 -like carbapenemase and evaluation of the antimicrobial resistance profiles of the isolates. Acta Microbiol. Immunol. Hung., 2010, 57(2), 87-94.
[http://dx.doi.org/10.1556/AMicr.57.2010.2.2] [PMID: 20587382]
[61]
Moradi-Tabriz, H.; Abdollahi, A.; Mehdipour, B.; Mahfoozi, S.A. baumannii, Infection Rate and Antimicrobial Susceptibility in an Iranian Tertiary Care Hospital. Iran. J. Pathol., 2010, 5(4), 194-198.
[62]
Jazani, N.; Zartoshti, M.; Babazadeh, H.; Ali-Daiee, N. Antibacterial effects of Artemisia dracunculus essential oil on multi-drug resistant isolates of Acinetobacter baumannii. Bact J., 2011, 1, 31-36.
[http://dx.doi.org/10.3923/bj.2011.31.36]
[63]
Shahcheraghi, F.; Akbari Shahmirzadi, N.; Jabbari, H.; Amirmozafari, N. Detection of blaCTX, blaTEMbeta-lactamase genes in clinical isolates of Acinetobacterspp. from selected Tehran hospitals. Indian J. Med. Microbiol., 2009, 3(1), 1-9.
[64]
Boroumand, M.; Akhyani, H.; Sheikhvatan, M.; Yazdi, S.H.; Saboorian, R.; Hashemi, S. Evaluation of antimicrobial resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test. Iran. J. Public Health, 2009, 38(2), 130-133.
[65]
Hosseini Jazani, N.; Babazadeh, H.; Khalkhali, H. An assessment of the sensitivity of Acinetobacter sp. burn isolates to Ciprofloxacin and some other antibiotics used for treatment. J Jahrom Univ Med Sci., 2009, 7(2), 48-58.
[66]
Khalatabadi-Farahani, R.M.R.; Shajari, G.H. The pattern of spread of antibiotic resistance and antibiotic resistance genes in Acinetobacter spp isolates from Shahi Beheshti hospital, Kashan. J Feyz, 2008, 12, 60-66.
[67]
Rahbar, M.; Monnavar, K.; Vatan, K.K.; Fadaei-haq, A.; Shakerian, F. Carbapenem resistance in gram-negative bacilli isolates in an Iranian 1000-bed Tertiary Hospital. Pak. J. Med. Sci., 2008, 24(4), 537-540.
[68]
Khosrishahi, N.; Sharifi, M. Isolation of carbapenem resistant Acinetobacter baumannii (CRAB) strains from patients and equipments of Intensive care units (ICUs) at Qazvin between 2005-2006. Indian J. Med. Microbiol., 2007, 1(3), 33-38.
[69]
Zarifi, E.; Eslami, G.; Khaledi, A.; Vakili, M.; Vazini, H.; Zandi, H. Prevalence of ESBLs in Acinetobacter baumannii isolated from intensive care unit (ICU) of Ghaem hospital, Mashhad, Iran. J. Pure Appl. Microbiol., 2017, 11(2), 811-820.
[http://dx.doi.org/10.22207/JPAM.11.2.20]
[70]
Nourbakhsh, F.; Rajai, M.; Momtaz, H. Antibiotic Resistance and Carriage Integron Classes in Clinical Isolates of Acinetobacter Baumannii from Isfahan Hospitals, Iran. Zahedan J. Res. Med. Sci., 2017, 19(1)
[http://dx.doi.org/10.17795/zjrms-6009]
[71]
Shamsizadeh, Z.; Nikaeen, M.; Nasr Esfahani, B.; Mirhoseini, S.H.; Hatamzadeh, M.; Hassanzadeh, A. Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections. Environ. Health Prev. Med., 2017, 22(1), 44.
[http://dx.doi.org/10.1186/s12199-017-0653-4] [PMID: 29165152]
[72]
Fallah, A.; Rezaee, M.A.; Hasani, A.; Barhaghi, M.H.S.; Kafil, H.S. Frequency of bap and cpaA virulence genes in drug resistant clinical isolates of Acinetobacter baumannii and their role in biofilm formation. Iran. J. Basic Med. Sci., 2017, 20(8), 849-855.
[PMID: 29085575]
[73]
Bagheri-Nesami, M.; Rezai, M.S.; Ahangarkani, F.; Rafiei, A.; Nikkhah, A.; Eslami, G.; Shafahi, K.; Hajalibeig, A.; Khajavi, R. Multidrug and co-resistance patterns of non-fermenting Gram-negative bacilli involved in ventilator-associated pneumonia carrying class 1 integron in the North of Iran. Germs, 2017, 7(3), 123-131.
[http://dx.doi.org/10.18683/germs.2017.1117] [PMID: 28932712]
[74]
Eghbalimoghadam, M.; Farahani, A.; Akbar, F.N.; Mohajeri, P. Frequency of Class 1 integron and genetic diversity of Acinetobacter baumannii isolated from medical centers in Kermanshah. J. Nat. Sci. Biol. Med., 2017, 8(2), 193-198.
[http://dx.doi.org/10.4103/0976-9668.210007] [PMID: 28781486]
[75]
Mohajeri, P.; Farahani, A.; Mehrabzadeh, R.S. Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from intensive care units in west of Iran. J. Clin. Diagn. Res., 2017, 11(2), DC20-DC22.
[http://dx.doi.org/10.7860/JCDR/2017/21156.9397] [PMID: 28384861]
[76]
BOKAIAN M. SHAHRAKI S RAEISI JM, MOHAMMADZADEH RF. Prevalence of OXA-2 and OXA-10 Type ESBL among Acinetobacter Strains Isolated from Patients of Zahedan; South Eastern Iran, 2016.
[77]
Moniri, R.; Farahani, R.K.; Shajari, G.; Shirazi, M.N.; Ghasemi, A. Molecular epidemiology of aminoglycosides resistance in acinetobacter spp. With emergence of multidrug-resistant strains. Iran. J. Public Health, 2010, 39(2), 63-68.
[PMID: 23113008]
[78]
Woodford, N.; Ellington, M.J.; Coelho, J.M.; Turton, J.F.; Ward, M.E.; Brown, S.; Amyes, S.G.; Livermore, D.M. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents, 2006, 27(4), 351-353.
[http://dx.doi.org/10.1016/j.ijantimicag.2006.01.004] [PMID: 16564159]
[79]
Sunenshine, R.H.; Wright, M-O.; Maragakis, L.L.; Harris, A.D.; Song, X.; Hebden, J.; Cosgrove, S.E.; Anderson, A.; Carnell, J.; Jernigan, D.B.; Kleinbaum, D.G.; Perl, T.M.; Standiford, H.C.; Srinivasan, A. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis., 2007, 13(1), 97-103.
[http://dx.doi.org/10.3201/eid1301.060716] [PMID: 17370521]
[80]
Pagano, M.; Martins, AF.; Barth, AL. Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii. Braz. J. Microbiol., 2016, 47(4), 785-92.
[81]
Torres, H.A.; Vázquez, E.G.; Yagüe, G.; Gómez, J.G. Acinetobacter baumanii multirresistente:situación clínica actual y nuevas perspectivas. Rev. Esp. Quimioter., 2010, 23(1), 12-19.
[PMID: 20232019]
[82]
Labarca, J.A.; Salles, M.J.C.; Seas, C.; Guzmán-Blanco, M. Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America. Crit. Rev. Microbiol., 2016, 42(2), 276-292.
[PMID: 25159043]
[83]
Kaase, M.; Nordmann, P.; Wichelhaus, T.A.; Gatermann, S.G.; Bonnin, R.A.; Poirel, L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother., 2011, 66(6), 1260-1262.
[http://dx.doi.org/10.1093/jac/dkr135] [PMID: 21427107]
[84]
Zong, Z.; Lü, X.; Valenzuela, J.K.; Partridge, S.R.; Iredell, J. An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int. J. Antimicrob. Agents, 2008, 31(1), 50-54.
[http://dx.doi.org/10.1016/j.ijantimicag.2007.08.019] [PMID: 18077141]
[85]
Suwantarat, N.; Carroll, K.C. Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia. Antimicrob. Resist. Infect. Control, 2016, 5(1), 15.
[http://dx.doi.org/10.1186/s13756-016-0115-6] [PMID: 27148448]
[86]
Moradi, J.; Hashemi, F.B.; Bahador, A. Antibiotic resistance of Acinetobacter baumannii in Iran: a systemic review of the published literature. Osong Public Health Res. Perspect., 2015, 6(2), 79-86.
[http://dx.doi.org/10.1016/j.phrp.2014.12.006] [PMID: 25938016]
[87]
Lemos, E.V.; de la Hoz, F.P.; Einarson, T.R.; McGhan, W.F.; Quevedo, E.; Castañeda, C.; Kawai, K. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin. Microbiol. Infect., 2014, 20(5), 416-423.
[http://dx.doi.org/10.1111/1469-0691.12363] [PMID: 24131374]

Rights & Permissions Print Cite
Article Metrics
7
© 2024 Bentham Science Publishers | Privacy Policy